Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions

Key facts

Study ID

NCT01331447

Run by

Roxane Laboratories

People needed

12

Starts

2004-05-01

Expected to finish

2004-05-01

Last updated by the study team

2018-01-23

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening

You may not qualify if…

• Positive test for HIV, Hepatitis B, or Hepatitis C.
• Treatment with known enzyme altering drugs.
• History of allergic or adverse response to exemestane or any comparable or similar product.

Where it is running

• BioKinetic Clinical Applications, Inc. — Springfield, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.